Delighted to share our latest publication on the use of an mRNA-based platform for TB vaccine development
🔗 tinyurl.com/yc5vvexw
A fantastic collaboration between @sydneyuni.bsky.social, Monash Institute of Pharmaceutical Sciences and @centenaryinstitute.bsky.social
#TB #vaccines #mRNA
tinyurl.com
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis
Mycobacterium tuberculosis remains the largest infectious cause of mortality worldwide, even with over a century of widespread administration of the o…